VERIF·AI
Sign in Run a check
Home › Companies › Research and experimental... › Argonaut Therapeutics Limited

Argonaut Therapeutics Limited

Active ·09993166 ·Private Limited Company ·Est. 8 February 2016
£117,528
Net Assets
£164,301
Cash
1
Officers
Total Exemption Full
Accounts
⚠️
Initial checks flagged a potential issue. Further analysis recommended before making a decision.
CONFIRMED SIGNAL
Accounts filed late
3076 days overdue
Confirmed from Companies House data Period end 28 Feb 2017 · due 29 Nov 2017
Full analysis checks for Argonaut Therapeutics Limited
  • 👤
    Director history and patterns Prior appointments, dissolved-company links, time-in-role across the cap table.
  • 📄
    Filing behaviour over time Lateness, restated accounts, confirmation-statement discipline across the last five years.
  • 📈
    Financial signals and trends Net assets, current liabilities, going-concern notes and year-on-year movement.
  • ✦
    Plain-English risk summary A clear paragraph telling you what these signals mean — and what to do about them.
Generated instantly from official filings and proprietary models.
🔒 Unlock the full report

Three ways to upgrade

If you check more than 2 companies a month, the £39 plan pays for itself.

  1. £99/mo · 30 Deep Dives Most popular
    £3.30 per report — the lowest rate
    Subscribe →
  2. £39/mo · 10 Deep Dives
    £3.90 per report — pays for itself after 2 reports
    Subscribe →
  3. £9 · 1 Deep Dive
    Single check, no subscription
    Buy £9 →

📊 Financial Snapshot — 28 February 2017

£117,528
Net Assets
£164,301
Cash
4
Employees
Source: Companies House filed accounts · Deep Dive: ratios, 10-year trends & AI analysis →

🏢 Company Details

Number09993166
StatusActive
TypePrivate Limited Company
Incorporated8 February 2016
IndustryResearch and experimental development on biotechnology
SIC72110
AccountsTotal Exemption Full

📍 Registered Address

Magdalen Centre Robert Robinson Avenue
Oxford
OX4 4GA
United Kingdom

👤 Directors & Officers (1)

Prof Nicholas Barrie La ThangueDIRECTOR

🔑 Persons with Significant Control (3)

Ingenox Therapeutics Limited75-100% shares
Oxford Science Enterprises PLC25-50% shares
Prof Nicholas Barrie La Thangue25-50% shares

🏗️ Corporate Group & Network

🔼 1 parent 🔗 5 connected companies
Ownership chain
Oxford Science Enterprises PLC25-50% shares
Argonaut Therapeutics LimitedThis company
Other companies sharing the same PSC
Celleron Therapeutics Limitedvia Prof Nicholas Barrie La Thangue 13423828via Prof Nicholas Barrie La Thangue Global Cancer Consultants Limitedvia Prof Nicholas Barrie La Thangue Ingenox Therapeutics Limitedvia Prof Nicholas Barrie La Thangue Canivax Limitedvia Prof Nicholas Barrie La Thangue
Network data from Companies House PSC register · Full network analysis in Deep Dive →
Health Score
73
Revenue Trend
Risk Signals
🔒

AI Intelligence Report

Health score, risk analysis, compliance & sanctions screening

Go Deeper on Argonaut Therapeutics Limited

Our AI reads their filings so you don't have to — full balance sheet & P&L analysis, health score, director network intelligence, FCDO sanctions screening, and a narrative you can actually understand.

✓ Free · magic link login · ✓ AI-powered · ✓ Ready in ~2 min
10-Year Financials Health Score Risk Flags FCDO Sanctions PDF Export
Generate Deep Dive & Track Argonaut...
Sign up and generate a Deep Dive for full AI analysis, ratios, trend charts and automatic filing alerts.
Run full company check — £9